COCP Cocrystal Pharma, Inc.

Earnings

Typical surprise +13.6% (median, so one quarter with a near-zero estimate can't distort it)

• Thu, Aug 13$-0.23 vs $-0.17miss
• Fri, May 15$-0.17 vs $-0.15miss
• Tue, Mar 31$-0.17 vs $-0.18beat
• Fri, Nov 14$-0.19 vs $-0.22beat
• Thu, Aug 14$-0.20 vs $-0.30beat
• Thu, May 15$-0.23 vs $-0.52beat

Estimates and results for COCP via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Insider trading

Open-market buys and sells by COCP officers and directors.

Bought

$2.4m

16 trades

Sold

$1.7m

1 trade

• Frost Phillip Md Et Albought
  director, 10 percent owner:·10,000 @ $0.98·$10k·Aug 5, 2026·filing
• Frost Phillip Md Et Albought
  director, 10 percent owner:·75,000 @ $0.94·$71k·Aug 3, 2026·filing
• Frost Phillip Md Et Albought
  director, 10 percent owner:·20,000 @ $1.00·$20k·Feb 24, 2026·filing
• Frost Phillip Md Et Albought
  director, 10 percent owner:·50,000 @ $0.95·$47k·Feb 6, 2026·filing
• Frost Phillip Md Et Albought
  director, 10 percent owner:·50,000 @ $0.95·$47k·Dec 31, 2025·filing
• Frost Phillip Md Et Albought
  director, 10 percent owner:·20,000 @ $0.97·$19k·Dec 30, 2025·filing
• Frost Phillip Md Et Albought
  director, 10 percent owner:·40,000 @ $0.97·$39k·Dec 26, 2025·filing
• Frost Phillip Md Et Albought
  director, 10 percent owner:·25,000 @ $0.97·$24k·Dec 24, 2025·filing

83 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.